Radiofrequency catheter ablation can lead to improvements in morbidity and mortality rates and quality of life for individuals with atrial fibrillation.
References
1.
Lloyd-JonesD. M.WangT. J.LeipE. P.LarsonM. G.LevyD.VasanR. S. (2004). Lifetime risk for development of atrial fibrillation. Circulation, 110, 1042–1046.
2.
PapponeC.RosanioS.AugelloG.GallusG.VicedominiG.MazzoneP. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Journal of the American College of Cardiology, 42(2), 185–197.
3.
VasanR. S.BenjaminE. J.SullivanL. M.D'AgostinoR. B. (2008). The burden of increasing worldwide cardiovascular disease. In FusterV.O'RourkeR. A.WalshR. A.Poole-WilsonP. (Eds.), Hurst's the heart. New York: McGraw-Hill.
4.
WilberD. J.PapponeC.NeuzilP.De PaolaA.MarchlinskiF.NataleA. (2010). Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation. Journal of the American Medical Association, 303(4), 333–340.
